Showing results (301-310 of 4,634) with videos related to
Sort By:
Pageof 464
Anti-Cancer Drugs|January 12, 2000
In vitro cellular accumulation and cytotoxicity of liposomal and conventional formulations of daunorubicin and doxorubicin in resistant K562 cellsY Wang, S Eksborg, R Lewensohn, et al.Anti-Cancer Drugs|January 12, 2000
Irinotecan in cancers of the lung and cervixA Sandler, A T van OosteromAnti-Cancer Drugs|January 12, 2000
New options in the treatment of non-small cell lung cancerF Fossella, J R Rigas, C P BelaniAnti-Cancer Drugs|November 26, 1999
Phase II study of raltitrexed (Tomudex) in chemotherapy-pretreated patients with advanced colorectal cancer. Tomudex Cooperative Study GroupA Sato, M Kurihara, N Horikoshi, et al.Anti-Cancer Drugs|November 26, 1999
Dendrimer-platinate: a novel approach to cancer chemotherapyN Malik, E G Evagorou, R DuncanAnti-Cancer Drugs|April 22, 1999
Role of red blood cells in pharmacokinetics of chemotherapeutic agentsD Schrijvers, M Highley, E De Bruyn, et al.Anti-Cancer Drugs|April 22, 1999
Phase II study of gemcitabine as first-line chemotherapy in patients with advanced or metastatic breast cancerK Possinger, M Kaufmann, R Coleman, et al.Anti-Cancer Drugs|April 22, 1999
Modulating effect of resveratrol and quercetin on oral cancer cell growth and proliferationT M ElAttar, A S VirjiAnti-Cancer Drugs|April 22, 1999
Inhibition of Na+,K+-ATPase by cisplatin and its recovery by 2-mercaptoethanol in human squamous cell carcinoma cellsN Sakakibara, K Suzuki, H Kaneta, et al.Anti-Cancer Drugs|April 22, 1999
Conventional dose melphalan is inactive in metastatic melanoma: results of an Eastern Cooperative Oncology Group Study (E1687)H Hochster, M H Strawderman, J E Harris, et al.Pageof 464